Recombinant Human IL-1 Protein，His

Interleukin-1 (IL-1) is a key pro-inflammatory cytokine involved in various immune responses, playing a crucial role in the pathogenesis of numerous diseases, including autoimmune disorders, inflammatory diseases, and cancer. Research on recombinant IL-1 proteins has gained significant attention due to their potential therapeutic applications. IL-1 exists in two main forms, IL-1α and IL-1β, both of which are synthesized as inactive precursors and require proteolytic cleavage for their activity. Investigating recombinant IL-1 proteins enables scientists to explore their biological functions, mechanisms of action, and signaling pathways, thereby advancing our understanding of inflammation and immune regulation. Furthermore, recombinant IL-1 proteins are valuable tools for studying the effects of this cytokine in vitro and in vivo, allowing for the development of novel therapies aiming to modulate IL-1 activity. For instance, IL-1 antagonists, such as anakinra, have already shown promise in treating conditions like rheumatoid arthritis. The exploration of IL-1's role in various diseases has also led to the identification of IL-1 as a potential target for immunotherapy, highlighting its importance in the evolving landscape of disease treatment strategies. Overall, the study of recombinant IL-1 proteins holds significant potential for advancing both basic and clinical research, providing insights that may translate into innovative therapeutic approaches.